CCN2 and scleroderma: CCN2/CTGF increased the expression of extracellular matrix molecules such as type I collagen, fibronectin, and integrin [13], and was overexpressed in fibroblasts in the dermis of patients with scleroderma [14] or other fibrotic disorders [15-18].